nothing unusual with medicine approval process with FDA. sentiment changes but fundamentally speaking , it is all about right track.
- Forums
- ASX - By Stock
- Ann: Neuren approaching key milestones in Q4 2019
nothing unusual with medicine approval process with FDA....
-
-
- There are more pages in this discussion • 114 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NEU (ASX) to my watchlist
|
|||||
Last
$15.70 |
Change
0.130(0.83%) |
Mkt cap ! $2.029B |
Open | High | Low | Value | Volume |
$15.40 | $16.06 | $15.36 | $3.126M | 198.9K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 129 | $15.69 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$15.71 | 243 | 6 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
6 | 83 | 15.710 |
5 | 560 | 15.700 |
6 | 635 | 15.690 |
4 | 410 | 15.680 |
4 | 790 | 15.670 |
Price($) | Vol. | No. |
---|---|---|
15.720 | 151 | 5 |
15.730 | 146 | 4 |
15.740 | 391 | 3 |
15.750 | 667 | 6 |
15.760 | 634 | 8 |
Last trade - 12.35pm 19/08/2024 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |